The Determination of Resorcyclic Acid Lactones in Biological Samples Using LC-MS/MS

Total Page:16

File Type:pdf, Size:1020Kb

The Determination of Resorcyclic Acid Lactones in Biological Samples Using LC-MS/MS Analytisch laboratorium voor voedings- en residue onderzoek SOP ARO/489 v 3 Printdatum: 1-Oct-08 r The determination of resorcyclic acid lactones in biological samples using LC-MS/MS Document: SOP ARO/489 versie 3 Auteur: Klaas van Twillert Documentgebied: ARO Methods Autorisator: Leen van Ginkel (labhoofd) Status: Definitief Pagina 1 van 10 Analytisch laboratorium voor voedings- en residue onderzoek SOP ARO/489 v 3 Printdatum: 1-Oct-08 r 1 Introduction Objective This SOP describes a quantitative method of analysis of α-zearalanol (Zeralanol), β-zearalanol (Taleranol), α-zearalenol, β-zearalenol, zearalanone and zearalenone in urine. The procedure for the same analysis carried out in liver is described as well, although this part was not validated. Therefore the performance characteristics given concern the analysis in urine. The clean-up consists of the following steps: deconjugation, liquid-liquid extraction, SPE extraction with C18 and amino. Separation and quantification is performed by liquid chromatography coupled via an electro spray interface to a mass spectrometer. Scope The method is used to perform quantitative and confirmation analysis of α-zearalanol (Zeralanol), β- zearalanol (Taleranol), α-zearalenol, β-zearalenol, zearalanone and zearalenone in urine of cattle, as well as in liver of cattle. The CCß is for α-zearalanol 0.20 ng/ml, β-zearalanol 0.47 ng/ml, α-zearalenol 0.34 ng/ml, β- zearalenol 0.48 ng/ml, zearalanone 0.23 ng/ml and zearalenone 0.29 ng/ml 3 Safety and environment The RIVM have defined rules to work safe. These rules can be found on insite. Waste is disposed according to SOP ARO/487. More information how to handle waste is found on the RIVM intranet. 4 Chemicals and reagents Reference to a company and/or product is for purpose of identification and information only. All reagents must be of analytical grade, unless otherwise specified 4.1 Water; Milli-Q, Waters. 4.2 Tertiair-ButylMethylEther (TBME). 4.3 Methanol 4.3.1 Methanol/water, 40/60 v/v-%: Mix 400 ml methanol with 600 ml water. 4.3.2 Methanol/water, 50/50 v/v-%: Mix 500 ml methanol with 500 ml water. 4.3.3 Methanol/water, 80/20 v/v-%: Mix 800 ml methanol with 200 ml water. 4.4 Acetone 4.4.1 Acetone/methanol, 80/20 v/v-%: Mix 800 ml acetone with 200 ml methanol. 4.5 β-glucuronidase (from Eschericha coli), Boehringer Mannheim, art.no 0307601001. 4.6 Hydrochloric acid, 37%. 4.6.1 HCl 1 M: Add 10 ml HCl to 90 ml water (proceed with caution). 4.7 HPLC eluentia: A(weak) methanol/water 5 mM NH4Ac, 10/90 v/v-%: mix 100 ml methanol with 900 ml water and 0.346 gram NH4Ac. B(strong) methanol/water 5 mM NH4Ac, 90/10 v/v-%: mix 900 ml methanol with 100 ml water and 0.038 gram NH4Ac. 4.8 Phosphate buffer 0.1 M, pH 7.0: Prepare a solution of 14.2 g Na2HPO4 (MW 142 g/mol) in 500 ml water. Prepare a solution of 13.6 g KH2PO4 (MW 136 g/mol) in 500 ml water. Add ca 360 ml of the KH2PO4 solution to the Na2HPO4 solution. Fill up till 1000 ml with water. 4.9 Acetic acid. Sodiumacetate. 4.10 Acetate buffer, 2 mol/l, pH 5.2. Dissolve 25.2 g of acetic acid and 129,5 g of sodiumacetate in 800 ml water. Adjust the pH with a pH meter to 5.2 ± 0.1 and add water to a final volume of 1000 ml. Pagina 2 van 10 Analytisch laboratorium voor voedings- en residue onderzoek SOP ARO/489 v 3 Printdatum: 1-Oct-08 r 4.11 Helix Pomatia Juice, Bio Sepra SA, (β-glucuronidase > 100.000 FU/ml, Sulfatase > 1000.000 RU/ml). 4.12 Bottles, 10 ml, brown glass, with screw cap. 4.13 SPE C18 column, 1 g, 6 ml, Alltech # 205430. 4.14 SPE NH2 column, 1 g, 6 ml, Alltech # 211153. 4.15 HPLC column: UPLC BEH C18, 1,7 µ, 2.1 x 100 mm. 4.16 Plastic centrifuge tubes, 50 ml. 4.17 Injection vials, Waters, 12 x 32 mm, glass screw neck vial, Quick Thread, LectraBond cap, preslit, PTFE/silicone septa. 4.18 The LC-MSMS equipment consists of a Waters Acquity UPLC system, a Waters Acquity autosampler and a Micromass Quattro Ultima Pt mass spectrometer. Reference standards and materials 4.19 Internal standards: Relevant internal standards are α-zearalanol-d4, β-zearalanol-d4, α- zearalenol-d4, β-zearalenol-d4 (source RIVM) and zearalenone-d6 (source DVS). 4.15.1 Stock solutions, containing 1 mg/ml, are prepared by dissolving the appropriate amount of the analyte in ethanol. These solutions are stored in the dark at -20 ºC for a maximum period of 5 year. 4.15.2 Working solutions, containing 0.1 mg/ml, are prepared by 10-fold dilutions of the stock solutions with ethanol. These solutions are stored in the dark at 4 ºC (range 1 – 10 ºC) for a maximum period of 6 months. 4.16 Standards: Relevant standards are α-zearalanol, β-zearalanol, α-zearalenol, β-zearalenol, zearalanone and zearalenone. 4.16.1 Stock solutions, containing 1 mg/ml, are prepared by dissolving the appropriate amount of the analyte in ethanol. These solutions are stored in the dark at -20 ºC for a maximum period of 5 year. 4.16.2 Working solutions, containing 0.1 mg/ml, are prepared by 10-fold dilutions of the stock solutions with ethanol. These solutions are stored in the dark at 4 ºC (range 1 – 10 ºC) for a maximum period of 6 months. Relevant data of the analytes are listed in table 1. Table 1: Information about analytes Analytes CAS # Formula Mol. Weight (g/mol) α-zearalanol 26538-44-3 C18H26O5 322,4 β-zearalanol 42422-68-4 C18H26O5 322,4 α-zearalenol 36455-72-8 C18H24O5 320,4 β-zearalenol 71030-11-0 C18H24O5 320,4 zearalanone 17924-92 C18H24O5 320,4 zearalenone 597578-0 C18H22O5 318,4 4.17 Preparation of a mixture of standards. 4.17.1 Pipette 0.1 ml of each of the standard working solutions (4.16.2) in a 10 ml bottle and fill up with ethanol until the total volume is 10 ml. This is the 0.001 mg/ml standard mixture. 4.17.2 Dilute this mixture (4.17.1) 1:10 by mixing 0.5 ml of this standard mixture with 4.5 ml ethanol in a 10 ml bottle. Concentration is 0.1 ng/µl. This mixture of standards is used to fortify blank matrix and to make the calibration curve. 4.18 Preparation of a mixture of internal standards. 4.18.1 Pipette 0.1 ml of each of the internal standard working solutions (4.15.2) in a 10 ml bottle and fill up with ethanol until the total volume is 10 ml. This is the 0.001 mg/ml internal standard mixture. Pagina 3 van 10 Analytisch laboratorium voor voedings- en residue onderzoek SOP ARO/489 v 3 Printdatum: 1-Oct-08 r 4.18.2 Dilute this mixture (4.18.1) 1:10 by mixing 0.5 ml of this internal standard mixture with 4.5 ml ethanol in a 10 ml bottle. Concentration is 0.1 ng/ul. This mixture of internal standards is used with the urine samples and the calibration curve. Preparation of the calibration curve. Transfer standard mixture and internal standard mixture according to table 2 in 2 ml sample vials. After pipetting the required amounts, these standards are further processed from section 5.22 onwards. Table 2. Calibration curve. ID *) µl standard 0.1 ng/μl µl internal standard 0.1 ng/μl 0 0 100 0.2 10 100 0.4 20 100 1.0 50 100 2.0 100 100 4.0 200 100 10.0 500 100 *) the value of ID gives the amount of standards in ng/ml sample. This value is calculated by dividing the total amount of standard by the amount sample in ml. 5 Procedure Procedure for urine 5.1 Transfer a portion of 5 ml of the urine samples in 50 ml plastic tubes. 5.2 Transfer a portion of 5 ml blank urine in a 50 ml plastic tube and fortify this blank with 50 μl of the mixture of standards (4.17.2). 5.3 Add 100 µl of the I.S.-mix (4.18.2) to these samples. 5.4 Adjust the pH of the urines to 7 ±0.3 with 1 M HCl. 5.5 Add 1 ml phosphatebuffer, pH 7 (4.8). 5.6 Add 50 μl β-glucuronidase and deconjugate during 2 hrs at 37 ºC (4.5) 5.7 Cool the samples to room temperature. 5.8 Bring 10 ml TBME into the tubes and rotate during 10 min. 5.9 Centrifuge the tubes for 10 min with 3600 rpm. 5.10 Transfer the upper (organic) layer into a glass test tube and evaporate the TBME at 60 ºC under a gentle stream of nitrogen. 5.11 Redissolve the residue in 5 ml methanol/water 50/50 vol-% by carefully vortexing. 5.12 Add 2 ml of water to make the polarity of the solution suitable for the next step (SPE). 5.13 SPE C18: Precondition the C18 column with 5 ml of methanol followed by 5 ml water. 5.14 Pass the sample through the column and wash with 5 ml 40/60 v/v-% methanol/water. 5.15 Dry the column before the next step by applying slight vacuum.
Recommended publications
  • Method for the Detection of Zeranol and SOP : ARO/442 Taleranol In
    TITLE: Method for the detection of zeranol and S.O.P. : ARO/442 taleranol in meat and liver Page : 1 of 9 . Revision : 0 Date : 990715 1. INTRODUCTION 1.1 Summary This SOP describes a screening and confirmation method for the determination of resorcyclic acid lactones (RAL’s) in meat and liver samples of bovine origin. A procedure is described for the detection of a-zearalanol (zeranol) and b-zearalanol (taleranol) by a combination of solid phase extraction (SPE) and GC-MS. The method consist of, digestion of the meat sample using the enzyme protease and hydrolysis of the liver sample using suc d’Helix Pomatia, extraction of the RAL’s with tert-butylmethylether (TBME), purification using reversed-phase C18 cartridges. This method can also be used for the metabolites a-zearalenol, b-zearalenol, zearalanone and zearalenone. When doing so validation for these compounds is necessary. 1.2 Field of application The method is used to perform routine screening in meat and liver samples and has proven to be suitable for the analysis of a-zearalanol and b-zearalanol. The limit of detection is 0.5 mg/g based on the detection of the most abundant diagnostic ions namely m/z 433 and m/z 437 for the internal standard, with a response at the correct retention time exceeding the signal to noise ratio of 3. The method is validated according to SOP ARO/425 (1.3.3). 1.3 References 1.3.1. H.J. van Rossum et al, Multi residue analysis anabolic agents, SOP ARO/113, revision 4, 21 January 1997, RIVM.
    [Show full text]
  • Étude in Vivo / in Vitro De L'effet De La Zéaralénone Sur L'expression De
    Étude in vivo / in vitro de l’effet de la zéaralénone sur l’expression de transporteurs ABC majeurs lors d’une exposition gestationnelle ou néonatale Farah Koraichi To cite this version: Farah Koraichi. Étude in vivo / in vitro de l’effet de la zéaralénone sur l’expression de transporteurs ABC majeurs lors d’une exposition gestationnelle ou néonatale. Toxicologie. Université Claude Bernard - Lyon I, 2012. Français. NNT : 2012LYO10314. tel-01071280 HAL Id: tel-01071280 https://tel.archives-ouvertes.fr/tel-01071280 Submitted on 3 Oct 2014 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. N° d’ordre 314-2012 Année 2012 THESE DE L’UNIVERSITE DE LYON Délivrée par L’UNIVERSITE CLAUDE BERNARD LYON 1 ECOLE DOCTORALE INTERDISCIPLINAIRE SCIENCES-SANTE (EDISS) DIPLOME DE DOCTORAT (arrêté du 7 août 2006) soutenue publiquement le 20 décembre 2012 par Mlle Farah KORAÏCHI TITRE : ETUDE IN VIVO/IN VITRO DE L’EFFET DE LA ZEARALENONE SUR l’EXPRESSION DE TRANSPORTEURS ABC MAJEURS LORS D’UNE EXPOSITION GESTATIONNELLE OU NEONATALE Directeur de thèse: Sylvaine LECOEUR Co-directeur
    [Show full text]
  • Annex D to the Report of the Panel to Be Found in Document WT/DS320/R
    WORLD TRADE WT/DS320/R/Add.4 31 March 2008 ORGANIZATION (08-0902) Original: English UNITED STATES – CONTINUED SUSPENSION OF OBLIGATIONS IN THE EC – HORMONES DISPUTE Report of the Panel Addendum This addendum contains Annex D to the Report of the Panel to be found in document WT/DS320/R. The other annexes can be found in the following addenda: – Annex A: Add.1 – Annex B: Add.2 – Annex C: Add.3 – Annex E: Add.5 – Annex F: Add.6 – Annex G: Add.7 WT/DS320/R/Add.4 Page D-1 ANNEX D REPLIES OF THE SCIENTIFIC EXPERTS TO QUESTIONS POSED BY THE PANEL A. GENERAL DEFINITIONS 1. Please provide brief and basic definitions for the six hormones at issue (oestradiol-17β, progesterone, testosterone, trenbolone acetate, zeranol, and melengestrol acetate), indicating the source of the definition where applicable. Dr. Boisseau 1. Oestradiol-17β is the most active of the oestrogens hormone produced mainly by the developing follicle of the ovary in adult mammalian females but also by the adrenals and the testis. This 18-carbon steroid hormone is mainly administered as such or as benzoate ester alone (24 or 45 mg for cattle) or in combination (20 mg) with testosterone propionate (200 mg for heifers), progesterone (200 mg for heifers and steers) and trenbolone (200 mg and 40 mg oestradiol-17β for steers) by a subcutaneous implant to the base of the ear to improve body weight and feed conversion in cattle. The ear is discarded at slaughter. 2. Progesterone is a hormone produced primarily by the corpus luteum in the ovary of adult mammalian females.
    [Show full text]
  • ACE Food Beverage Applications Guide
    Food and Beverage Applications Guide Ultra-Inert Base Deactivated UHPLC / HPLC Columns Contents Application Index 1 Analyte Index 2 - 4 Application Notes 5 - 90 Send us your application and receive a free ACE column Send us your application on an ACE column and help extend our applications database. Your proven method will enable your chromatography colleagues to benefit and if we select your application for publication we’ll send you a FREE ACE analytical column of your choice. To submit your application e-mail us at: [email protected] ACE ® Food and Beverage Applications: Application Index Application Pages Application Pages Additives and intense sweeteners 5 Organic acids 2 47 Argicultural pesticides 6 Organic acids 3 48 Amino acids in peas 7 Organic acids 4 49 Amino acids and biogenic amines in wine and beer 8 Organophosphorus flame retardants in water by LC-MS/MS 50 Aminoglycosides in eggs 9 Organophosphorus isomer flame retardants in water 51 Annatto 10 Paraben preservatives 52 Anthocyanins from sambucus nigra (elderberry) 11 Perfluoro acids by LC-MS/MS 53 Appetite suppressants by LC-MS 12 Perfluoroalkyl substances by ion pairing LC-MS/MS 54 Arsenolipids from edible seaweed 13 Perfluorinated compounds in water by LC-MS/MS 55 Artificial colours (water soluble) 14 Pesticides (250 analytes) by LC-MS/MS 56 Artificial food colouring 15 Pesticides (47 analytes) by LC-MS/MS 60 Artificial sweeteners global method 16 Pesticides in water 61 Artificial sweeteners (stevia glycosides) 17 Phenolic compounds in ground water and landfill leachates
    [Show full text]
  • Compound CAS
    https://www.fermentek.com inhoud: Compound CAS# 100ìg 15 Acetoxyscirpenol 2623-22-5 1 mg 15-Acetyl-DON 88337-96-6 5mg 17-AAG 75747-14-7 10mg 17-DMAG 467214-20-6 25mg 3-Acetyl-DON 50722-38-8 50mg 7-Amino-Actinomycin D 7240-37-1 100mg A23187 Ca-Mg 52665-69-7 250mg A23187, 4-Bromo 76455-48-6 500mg A23187, free acid 52665-69-7 1gr Actinomycin D (≥ 97%) 50-76-0 5gr Actinomycin D (≥ 99%) 50-76-0 Aflatoxicol 29611-03-8 Aflatoxin B1 1162-65-8 Aflatoxin B2 7220-81-7 Aflatoxin G1 1165-39-5 Aflatoxin G2 7241-98-7 Aflatoxin M1 6795-23-9 Aflatoxin M2 6885-57-0 Alamethicin 27061-78-5 Alpha Zearalanol 26538-44-3 Alpha Zearalenol 36455-72-8 Altenuene 889101-41-1 Alternariol 641-38-3 Alternariol monomethyl Ether 26894-49-5 Altertoxin l 56258-32-3 Anisomycin 22862-76-6 Ansamitocin P3 66584-72-3 Antimycin A 1397-94-0 Aphidicolin 38966-21-1 Apicidin 183506-66-3 Ascomycin 11011-38-4 Aureothricin 574-95-8 Bafilomycin A1 88899-55-2 Bafilomycin B1 88899-56-3 Beauvericin 26048-05-5 Beta Zearalanol 42422-68-4 Beta Zearalenol 71030-11-0 Blasticidin S.HCl 9-3-3513 Borrelidin 7184-60-3 Brefeldin A 20350-15-6 Castanospermine 79831-76-8 Celastrol (tripterine) 34157-83-0 Cercosporin 35082-49-6 Cerulenin 17397-89-6 Chaetocin 28097-03-2 Chaetoglobosin A 50335-03-0 Chelerythrine Cl 3895-92-9 Chromomycin A3 7059-24-7 Citreoviridin 25425-12-1 Citrinin 518-75-2 Concanamycin A 80890-47-7 Cordycepin 73-03-3 Curvularin 10140-70-2 Cyclopamine 4449-51-8 Cyclopiazonic Acid 18172-33-3 Cytochalasin E 36011-19-5 Cytochalasin A 14110-64-6 Cytochalasin B 14930-96-2 Cytochalasin C 22144-76-9
    [Show full text]
  • 03-Speranda.Vp:Corelventura
    Acta Veterinaria (Beograd), Vol. 56, No. 2-3, 121-136, 2006. DOI: 10.2298/AVB0603121S UDK 619:636.4.087.7 HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS OF WEANED PIGLETS FED ON FODDER MIXTURE CONTAMINATED BY ZEARALENONE WITH ADDITION OF CLINOPTILOLITE [PERANDA MARCELA*, LIKER B**, [PERANDA T*, [ERI] V***, ANTUNOVI] Z*, GRABAREVI] @****, SEN^I] \*, GRGURI] D***** and STEINER Z* *Faculty of Agriculture, Osijek, Croatia; **Faculty of Agriculture, Zagreb, Croatia; ***Clinical Hospital Osijek, Croatia; ****Faculty of Veterinary Medicine, Zagreb, Croatia; *****Centar for Livestock Improvement, Osijek (Received 20. October 2005) The effect of zeolite clinoptilolite (CLIN) on some metabolic parameters in blood serum and haematological values in weaned piglets fed with increased levels of zearalenone (ZEN) was investigated over a 14-day period. The research involved four groups of weaned piglets aged 40 to 54 days. All groups were fed on fodder mixture for growing pigs containing 20% crude protein and 12.57 MJ ME/kg. The first control group (C1) received a concentrate mixture without added ZEN or mycotoxin adsorbent Min-a-Zel Plus®. The second control group (C2) was fed on fodder mixture containing 0.2% of modified clinoptilolite (Min-a-Zel Plus®; levels of zearalenone <5.1 ng/g). Piglets in the experimental group (E1) were fed on fodder mixture containing added zeralenone (3 mg/kg) (Sigma-Aldrich Co) and 0.2% of Min-a-Zel Plus® preparation. The second experimental group (E2) was fed on fodder mixture to which 3 mg/kg of zearalenone was added, but with no addition of Min-a-Zel Plus®. Oestrogenic effect of ZEN was evident in the sinergistic action with insulin which was manifested in an increased total protein level, lower level of glucose, triacylglycerols, serum iron, a higer level of cholesterol and higher aminotransaminase activity.
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • TGA Review of Hgps
    A REVIEW TO UPDATE AUSTRALIA’S POSITION ON THE HUMAN SAFETY OF RESIDUES OF HORMONE GROWTH PROMOTANTS (HGPs) USED IN CATTLE Prepared by Chemical Review and International Harmonisation Section Office of Chemical Safety Therapeutic Goods Administration of the Department of Health and Ageing Canberra July 2003 A draft of this report was tabled at the 25th Meeting of the Advisory Committee on Pesticides and Health (ACPH), held in Canberra on the 1st May 2003. The report was subsequently endorsed out-of-session by the ACPH. Hormone Growth Promotants TABLE OF CONTENTS ABBREVIATIONS ................................................................................................................................................................4 EXECUTIVE SUMMARY ..................................................................................................................................................7 INTRODUCTION..................................................................................................................................................................9 HEALTH CONCERNS ASSOCIATED WITH HGP S................................................................................................................9 DIFFICULTIES ASSOCIAT ED WITH ASSESSING THE SAFETY OF HGPS.........................................................................10 RISK ASSESSMENTS OF HGP S .........................................................................................................................................10 PURPOSE OF THE CURRENT
    [Show full text]
  • NORMATIVE INSTRUCTION 5 of APRIL 23, 2019 (Published in the Official Gazette of the Federal Government (DOU) on 25/04/2019)
    NORMATIVE INSTRUCTION 5 OF APRIL 23, 2019 (Published in the Official Gazette of the Federal Government (DOU) on 25/04/2019) THE SECRETARY FOR ANIMAL AND PLANT HEALTH OF THE MINISTRY OF AGRICULTURE, LIVESTOCK AND FOOD SUPPLY, using the power attributed to him by Articles 21 and 63, of Appendix I, of Decree 9,667, of January 2, 2019, taking into consideration what is set forth in Ordinance (Portaria) 51, of February 6, 1986, Ordinance (Portaria) 527 of August 15, 1995, SDA Normative Instruction 42 of December 20, 1999, Decree 9,013 of March 29, 2017; and what is set forth in Case File 21000.022222/2019-71, resolves: Article 1. To approve the publication of the sampling plan and the reference limits for the National Plan for the Control of Residues and Contaminants in Animal Products - PNCRC of 2019, for the chains of beef, pork, goat, mutton, equine, rabbit, poultry, ostrich meat, and milk, fisheries, honey and eggs. Paragraph 1. The sampling plan and limits of reference stated in the heading hereof will be published in the Ministry of Agriculture, Livestock and Food Supply. Article 2. The tests for the Monitoring and Exploratory Subprogram of the PNCRC described in Article 1 herein are be performed in the official and authorized laboratories of the National Network of Agricultural Laboratories of the Unified System for Animal and Plant Health, as established by Normative Instruction 57 of December 11, 2013. Article. 3 This Normative Instruction shall come into force as of the date of its publication. JOSÉ GUILHERME TOLLSTADIUS LEAL TABLE
    [Show full text]
  • World Mycotoxin Journal, February 2014; 7 (1): 3-33 Publishers
    Wageningen Academic World Mycotoxin Journal, February 2014; 7 (1): 3-33 Publishers Developments in mycotoxin analysis: an update for 2012-2013 F. Berthiller1, P.A. Burdaspal2, C. Crews3, M.H. Iha4, R. Krska1, V.M.T. Lattanzio5, S. MacDonald3, R.J. Malone6, C. Maragos7, M. Solfrizzo5, J. Stroka8 and T.B. Whitaker9 1University of Natural Resources and Life Sciences, Vienna, Department for Agrobiotechnology (IFA-Tulln), Christian Doppler Laboratory for Mycotoxin Metabolism and Center for Analytical Chemistry, Konrad Lorenz Str. 20, 3430 Tulln, Austria; 2National Centre for Food, Spanish Food Safety and Nutrition Agency, Carretera de Majadahonda a Pozuelo km 5, 228220 Majadahonda, Spain; 3The Food and Environment Research Agency, Sand Hutton, York YO41 1LZ, United Kingdom; 4Instituto Adolfo Lutz, Laboratrio I de Ribeiro Preto, Av Dr Arnaldo 355, CEP 14085-410, Ribeiro Preto SP, Brazil; 5Institute of Sciences of Food Production, National Research Council, Via Amendola 122/o, Bari 700126, Italy; 6Trilogy Analytical Laboratory, 870 Vossbrink Drive, Washington, MO 63090, USA; 7USDA, ARS National Center for Agricultural Utilization Research, 1815 N. University St., Peoria, IL 61604, USA; 8Institute for Reference Materials and Measurements (IRMM), European Commission Joint Research Centre, Retieseweg 111, 2440 Geel, Belgium; 9Biological and Agricultural Engineering Department, N.C. State University, P.O. Box 7625, Raleigh, NC 27695-7625, USA; [email protected] Received: 12 September 2013 / Accepted: 2 December 2013 © 2014 Wageningen Academic Publishers REVIEW ARTICLE Abstract This review highlights developments in mycotoxin analysis and sampling over a period between mid-2012 and mid-2013. It covers the major mycotoxins: aflatoxins, Alternaria toxins, ergot alkaloids, fumonisins, ochratoxins, patulin, trichothecenes and zearalenone.
    [Show full text]
  • WT/DS320/R Page 141
    WT/DS320/R Page 141 (b) Summary of the main arguments of the parties315 7.2 With reference to the Panel's question whether panels are permitted to open hearings to public observation under Articles 12 (including Appendix 3), 14.1 and 17.10 of the DSU, the European Communities argues that a panel may adopt working procedures that foresee open hearings, as Article 12.1 of the DSU provides that panels may depart from the working procedures in Appendix 3 after consulting the parties to the dispute. 7.3 The European Communities also argues that this conclusion is not affected by Article 14.1 of the DSU on confidentiality of panel deliberations. The term "deliberations" does not cover the meetings with the parties, for which a different terminology is used in Appendix 3 of the DSU. 7.4 The European Communities considers that in the present case where all the parties have agreed to open hearings, the Panel should accommodate the parties' request. Article 18.2 of the DSU also supports the position that parties are entitled to "waive" the confidentiality of their positions. 7.5 Regarding the legal implications of open hearings on covered persons under the Rules of Conduct, the European Communities considers that no legal issues arise under the Rules of Conduct. In the European Communities view, the Rules of Conduct are and remain fully binding on all covered persons in this dispute, even if the hearings are opened to the public. The Panel's deliberations will in any event not be affected by the opening and remain confidential, as required by Article 14.1 of the DSU.
    [Show full text]
  • Wo 2008/127291 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 23 October 2008 (23.10.2008) WO 2008/127291 A2 (51) International Patent Classification: Jeffrey, J. [US/US]; 106 Glenview Drive, Los Alamos, GOlN 33/53 (2006.01) GOlN 33/68 (2006.01) NM 87544 (US). HARRIS, Michael, N. [US/US]; 295 GOlN 21/76 (2006.01) GOlN 23/223 (2006.01) Kilby Avenue, Los Alamos, NM 87544 (US). BURRELL, Anthony, K. [NZ/US]; 2431 Canyon Glen, Los Alamos, (21) International Application Number: NM 87544 (US). PCT/US2007/021888 (74) Agents: COTTRELL, Bruce, H. et al.; Los Alamos (22) International Filing Date: 10 October 2007 (10.10.2007) National Laboratory, LGTP, MS A187, Los Alamos, NM 87545 (US). (25) Filing Language: English (81) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of national protection available): AE, AG, AL, AM, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY,BZ, CA, CH, (30) Priority Data: CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, 60/850,594 10 October 2006 (10.10.2006) US ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, (71) Applicants (for all designated States except US): LOS LR, LS, LT, LU, LY,MA, MD, ME, MG, MK, MN, MW, ALAMOS NATIONAL SECURITY,LLC [US/US]; Los MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, Alamos National Laboratory, Lc/ip, Ms A187, Los Alamos, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, NM 87545 (US).
    [Show full text]